Literature DB >> 9041205

Cloning of a novel protein overexpressed in human mammary carcinoma.

F Bachmann1, R Bänziger, M M Burger.   

Abstract

A novel Mr 150,000 protein (p150), which was found to be preferentially expressed in virally and oncogene transformed mouse cells, was partially purified, and the cDNA was cloned. p150 is the largest member of a putative protein family, the molecular function of which is as yet unknown. Its pattern of expression correlates well not only with transformation but also with the dedifferentiated state of several mouse cell lines and cells. Furthermore, human breast carcinoma specimens and normal tissue from the same breast were screened for the presence of the p150 antigen. In all carcinoma samples, Western blotting revealed higher p150 expression levels than that in control tissue from the same patient. Immunohistochemical analyses of the same specimens displayed specific staining of the carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041205

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

Review 1.  Translational control in cancer.

Authors:  Deborah Silvera; Silvia C Formenti; Robert J Schneider
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

2.  Knockdown of eIF3d inhibits cell proliferation through G2/M phase arrest in non-small cell lung cancer.

Authors:  Zhifeng Lin; Liwen Xiong; Qiang Lin
Journal:  Med Oncol       Date:  2015-05-26       Impact factor: 3.064

3.  The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer.

Authors:  Yi Gao; Jingfei Teng; Yi Hong; Fajun Qu; Jizhong Ren; Lin Li; Xiuwu Pan; Lu Chen; Lei Yin; Danfeng Xu; Xingang Cui
Journal:  Med Oncol       Date:  2015-06-03       Impact factor: 3.064

4.  Translational regulation of RPA2 via internal ribosomal entry site and by eIF3a.

Authors:  Ji-Ye Yin; Zi-Zheng Dong; Ran-Yi Liu; Juan Chen; Zhao-Qian Liu; Jian-Ting Zhang
Journal:  Carcinogenesis       Date:  2013-02-07       Impact factor: 4.944

5.  The translation initiation factor eIF3i up-regulates vascular endothelial growth factor A, accelerates cell proliferation, and promotes angiogenesis in embryonic development and tumorigenesis.

Authors:  Yike Yuan; Yaguang Zhang; Shaohua Yao; Huashan Shi; Xi Huang; Yuhao Li; Yuquan Wei; Shuo Lin
Journal:  J Biol Chem       Date:  2014-08-21       Impact factor: 5.157

6.  The cholangiocyte marker, BD. 1, forms a stable complex with CLIP170 and shares an identity with eIF3a, a multifunctional subunit of the eIF3 initiation complex.

Authors:  David R Mills; Rebecca A Rozich; Donna L Flanagan; Kate E Brilliant; DongQin Yang; Douglas C Hixson
Journal:  Exp Mol Pathol       Date:  2012-05-18       Impact factor: 3.362

Review 7.  N6-methyladenine RNA modification and cancer.

Authors:  Jun Yang; Junwen Chen; Xiang Fei; Xia Wang; Kefeng Wang
Journal:  Oncol Lett       Date:  2020-06-16       Impact factor: 2.967

8.  EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression.

Authors:  Zizheng Dong; Jian-Ting Zhang
Journal:  Mol Biol Cell       Date:  2003-05-29       Impact factor: 4.138

9.  A systematic analysis of miRNA transcriptome in Marek's disease virus-induced lymphoma reveals novel and differentially expressed miRNAs.

Authors:  Ling Lian; Lujiang Qu; Yanmei Chen; Susan J Lamont; Ning Yang
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

10.  The let-7 microRNA interfaces extensively with the translation machinery to regulate cell differentiation.

Authors:  Xavier C Ding; Frank J Slack; Helge Grosshans
Journal:  Cell Cycle       Date:  2008-10-12       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.